- Home
- NGG vs ABT Comparison
NGG vs ABT Comparison
Compare NGG & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGG | ABT |
|---|---|---|
| Founded | 1990 | 1888 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.4B | 152.9B |
| IPO Year | 2000 | 2006 |
Fundamental Metrics
Financial Performance| Metric | NGG | ABT |
|---|---|---|
| Price | $81.17 | $116.11 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 20 |
| Target Price | N/A | ★ $130.90 |
| AVG Volume (30 Days) | 757.3K | ★ 5.8M |
| Earning Date | 05-14-2026 | 04-16-2026 |
| Dividend Yield | ★ 3.59% | 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | N/A | $10.75 |
| Revenue Next Year | $11.17 | $8.10 |
| P/E Ratio | ★ $115.91 | $191.25 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $67.52 | $81.97 |
| 52 Week High | $94.64 | $137.49 |
Technical Indicators
Market Signals| Indicator | NGG | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 48.09 | 75.26 |
| Support Level | $79.32 | $111.18 |
| Resistance Level | $82.34 | $116.82 |
| Average True Range (ATR) | 0.89 | 2.06 |
| MACD | 0.05 | 0.22 |
| Stochastic Oscillator | 48.74 | 89.30 |
Price Performance
Historical ComparisonAbout NGG National Grid Transco PLC National Grid PLC (NEW)
National Grid owns and operates the electric transmission system in England and Wales. It sold the bulk of its UK gas transmission business in fiscal 2023 to fund the acquisition of PPL's UK power distribution assets. In the Northeastern United States, it serves electricity and gas customers combined in three states. It also owns regulated transmission electricity networks in the United States, metering services and merchant transmission lines in the UK.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.